Cathie's Ark LogoCathie's Ark
Trading Floor Community IconFrom the Trading Floor:
Beam Therapeutics Inc Logo

ARKG Holdings of Beam Therapeutics (BEAM) - Updated Daily

Lock Icon
Fund Weight
October 12, 2021BUY151670.0198%ARKG
October 11, 2021BUY238720.0298%ARKG
October 8, 2021BUY377530.0455%ARKG
October 6, 2021BUY758620.09%ARKG
October 5, 2021BUY120940.0149%ARKG

Key Statistics

🕵🏼Found In🏷Last Price
⚖️Weighting🧢Market Cap
🏋🏿‍♂️Weight Rank In ARKG🧮Price to Sales
🏋️‍♀️Weight Rank Across All Funds🌏Country
19🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that enables precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Research Notes and Commentary for BEAM